Skip to content

Author

Hong-Xiang Wei

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

RASGRP2 promotes doxorubicin chemoresistance and tumor progression in osteosarcoma via the Notch1-NICD-Hes1 axis.

BACKGROUND Doxorubicin (DOX) resistance remains a major obstacle to favorable outcomes in osteosarcoma. The role of RASGRP2 in osteosarcoma chemoresistance is poorly understood. METHODS We analyzed RASGRP2 expression and prognostic value across pan-cancer datasets (TCGA, TARGET) and osteosarcoma cohorts (TARGET-OS, G...

Xue-Yi Huang, Zhen Huang, Mei-Xiu Lin et al. · 0 citations
Review Aug 2026

Association between inflammatory score and incident cancer risk among middle-aged and older Chinese adults: a prospective cohort study from CHARLS.

BACKGROUND Chronic inflammation is a recognized driver of carcinogenesis. The inflammatory score, a composite metric integrating C-reactive protein (CRP) and white blood cell (WBC) counts, offers a systematic assessment of systemic inflammatory burden. However, prospective evidence linking inflammatory score (IS) with...

Fan Zhang, Hong-Xiang Wei, Jing Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.